AZD 2066 hydrate

AZD 2066 hydrate is a brain-penetrant and orally bioavailable mGluR5 antagonist with selectivity. It demonstrates analgesic properties in preclinical models, supporting its research use in neuropharmacology and pain studies involving both in vitro receptor assays and in vivo behavioral experiments.